21.20NOK-5.78%Mkt Cap: 1.08B NOKP/E: 81.54Last update: 2026-06-01
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp a…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.08B NOK
Enterprise Value904.17M NOK
Revenue (TTM)128.37M NOK
Gross Profit107.75M NOK
Net Income (TTM)9.74M NOK
Revenue/Share2.434 NOK
Last Price21.20 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees50
CountryNO
SectorHealthcare
IndustryBiotechnology
ISINNO0010014632
Valuation
P/E (Trailing)81.54
P/E (Forward)35.77
PEG—
EV/EBITDA76.98
EV/Revenue7.04
P/S8.95
P/B3.38
EPS (TTM)0.28
EPS (Forward)0.63
52W Range
15.0038% of range31.40
52W High31.40 NOK
52W Low15.00 NOK
Profitability
Gross Margin95.68%
Oper. Margin-2.15%
EBITDA Margin9.15%
Profit Margin8.65%
ROE2.88%
ROA2.70%
Growth
Revenue Growth40.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF25.80M NOK
CapEx (TTM)3.64M NOK
FCF Margin10.68%
FCF Yield1.27%
Net Debt-244.94M NOK
Net Debt/EBITDA-20.85
Balance Sheet
Debt/Equity0.02
Current Ratio15.83
Quick Ratio14.80
Book Value/Sh6.663 NOK
Cash/Share5.171 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)31.00 NOK
Target Range28.00 NOK – 34.00 NOK
# Analysts2
Ownership
Shares Out.51.07M
Float42.10M
Insiders17.51%
Institutions14.85%
Technical
SMA 5020.19 (+5.0%)
SMA 20023.39 (-9.4%)
Beta0.51
S&P 52W Chg27.70%
Avg Vol (30d)76.25K
Avg Vol (10d)43.95K
Technical Indicators
RSI (14)63.2
MACD0.0736
MACD Signal-0.0607
MACD Hist.+0.1343
BB Upper23.18 NOK
BB Middle20.80 NOK
BB Lower18.42 NOK
BB Width22.88%
ATR (14)0.9702 NOK
Vol Ratio (20d)1.14x